Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gene Therapy Reviews Return To US FDA Advisory Committee Schedule

Apr 20 2022

• By Ramsey Baghdadi

gene therapy syringe — • Source: Alamy

Related Content

CellTrans’ Donislecel Gets US FDA Panel Nod For Small Group Of Type 1 Diabetics

Apr 16 2021

Gene Therapy: AAV Doses Should Not Be Subject To Fixed Upper Limit, US FDA Panel Says

Sep 09 2021

Spark's Gene Therapy Luxturna Sails Through US FDA Panel

Oct 13 2017

US FDA’s Overloaded Advanced Therapies Office Eyes Organizational, Communication Changes

Dec 09 2021

Related Companies

Genetix Biotherapeutics

Spark Therapeutics, Inc.

Novartis AG

CellTrans, Inc.

Additional Topics

United States Gene Therapy Advisory Committees Drug Review Drug Approval Standards Regulation Neurology BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window